By Léon Van Wouwe, Clinical Innovation Director, Volv Global ASCO 2026 produced landmark oncology data. The question no one
Press Release Épalinges, Switzerland, June 15th, 2026 Cross-industry white paper calls for three paradigm shifts to unlock orphan drug
Paradigm shifts and strategic recommendations from Volv Global, Sanofi, Fondation Ipsen, Unitechpharma, and brave2change Orphan drug development faces barriers: approximately
Pompe disease is a rare, chronically debilitating metabolic disorder caused by deficiency of the enzyme acid alpha-glucosidase. As enzyme replacement
Press Release Épalinges, Switzerland, June 1st, 2026 Machine Learning Maps and Discovers Clinical Endpoints in Pompe Disease Using Real-World
Tech Tour Growth Health is one of Europe’s most established gatherings at the intersection of healthcare innovation and investment –
